Target intelligence / Profile preview

Cell-surface attachment factors for adeno-associated virus capsid (AAV attachment factors)

Target
AAV attachment factors
Molecular classification
Glycan, Proteoglycan, Polysaccharide
01

Overview

Cell-surface attachment factors for adeno-associated virus (AAV) capsids are a diverse class of molecules, primarily glycans and proteoglycans, that mediate the initial, low-affinity binding of the virus to the host cell surface. These factors, which include heparan sulfate proteoglycans (HSPG), sialic acid, and galactose, serve to sequester and concentrate AAV particles at the plasma membrane, facilitating subsequent interactions with high-affinity entry receptors such as the universal AAV receptor (AAVR/KIAA0319L). The specific attachment factor utilized is a primary determinant of the tissue tropism and transduction efficiency of different AAV serotypes; for example, AAV2 and AAV3 utilize HSPG, while AAV1 and AAV5 target sialic acid, and AAV9 binds to terminal galactose. In the field of gene therapy, these factors are critical targets for capsid engineering aimed at redirecting viral delivery to specific tissues or evading pre-existing neutralizing antibodies. While AAV is non-pathogenic, the ubiquitous nature of these attachment factors can lead to therapeutic challenges, such as the sequestration of vectors in the liver or other non-target organs. Understanding and modulating these interactions is essential for optimizing the safety and efficacy of recombinant AAV (rAAV) products.

Other names
Heparan sulfate proteoglycanHSPGSialic acidGalactoseAAV primary receptorsGlycan attachment factorsN-linked glycansO-linked glycans
02

Mechanism of action

Competitive inhibition of viral binding to cell surface glycans or enzymatic removal of glycan moieties to prevent viral attachment.

03

Biological functions

Viral attachmentCell surface sequestrationViral tropismCell adhesion
04

Disease associations

Infection
05

Safety considerations

Off-target tissue transductionLiver sequestrationPre-existing neutralizing antibodiesVariability in glycan expression
06

Interacting drugs

Heparin

3 more in the full profile.

07

Biomarkers

HSPG expression levelSialic acid densityGalactose expression

Beyond the preview

Go deeper on Cell-surface attachment factors for adeno-associated virus capsid (AAV attachment factors).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface attachment factors for adeno-associated virus capsid (AAV attachment factors).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call